Can-Fite BioPharma Ltd. (CANF) Total liabilities 2018–2025
Can-Fite BioPharma Ltd. (CANF) total liabilities at each fiscal year-end, per SEC filings.
$3.9MFY2025 · since FY2018: $4.9M → $3.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3.9M | +6.5% |
| FY2024 | $3.7M | -1.7% |
| FY2023 | $3.7M | -22.1% |
| FY2022 | $4.8M | -18.1% |
| FY2021 | $5.9M | +70.2% |
| FY2020 | $3.4M | -39.8% |
| FY2019 | $5.7M | +16.1% |
| FY2018 | $4.9M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice